US stocks slump as market digests Trump health setback

The Dow Jones Industrial Average was at 20,427.39, down 0.8 percent.

Published: 27th March 2017 07:00 PM  |   Last Updated: 27th March 2017 07:00 PM   |  A+A-

President Donald Trump speaks in the East Room of the White House in Washington, Tuesday, March 7, 2017, during a meeting with the Republican House whip team about the proposed health bill. | AP


NEW YORK: Wall Street stocks fell early Monday in the first full session since Republican leaders withdrew a US health care reform bill, dealing a major setback to President Donald Trump.

About 10 minutes into trading, US stocks were solidly lower, a more decisive reaction to the surprise outcome in Congress compared with Friday, when the market finished the session mixed in the brief period of trading after the bill died. 

The Dow Jones Industrial Average was at 20,427.39, down 0.8 percent.

The broad-based S&P 500 dropped 0.9 percent to 2,324.07, as did the tech-rich Nasdaq Composite Index which was down to 5,774.65.

Analysts said the demise of the health care replacement, Trump's first major legislative effort, raised questions about the new president's ability to advance the rest of his agenda.

"The prospects for tax reform, regulatory change and fiscal stimulus have helped fuel the post-election market rally, but last week's failed attempt at healthcare reform has put a dent in confidence around the administration's ability to effectively accomplish those initiatives," according to

Hospital stocks HCA and Universal Health Services rose 4.5 percent and 3.2 percent, respectively, as the chance of a major overhaul threatening federal programs key to their businesses subsided.

But large banks fell again, with JPMorgan Chase losing 1.8 percent and Goldman Sachs 2.7 percent. The sector was one of the biggest beneficiaries of post-election investor bullishness, on the hopes of tax cuts and regulatory reform.

Dow Chemical shed 0.6 percent and DuPont 0.5 percent as European Union antitrust authorities approved the $130 billion merger of the two companies, provided DuPont sells "major parts" of its global pesticides business.

Stay up to date on all the latest World news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp